These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 18805553)

  • 41. Diabetes and cardiovascular disease: explaining the relationship.
    Punthakee Z; Werstuck GH; Gerstein HC
    Rev Cardiovasc Med; 2007; 8(3):145-53. PubMed ID: 17938614
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Diabetic vascular disease: an experimental objective.
    Goldberg IJ; Dansky HM
    Arterioscler Thromb Vasc Biol; 2006 Aug; 26(8):1693-701. PubMed ID: 16763160
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Endothelial dysfunction: causes and consequences in patients with diabetes mellitus.
    Avogaro A; de Kreutzenberg SV; Fadini G
    Diabetes Res Clin Pract; 2008 Dec; 82 Suppl 2():S94-S101. PubMed ID: 18954919
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hypoglycemic pharmacological treatment of type 2 diabetes: targeting the endothelium.
    Nathanson D; Nyström T
    Mol Cell Endocrinol; 2009 Jan; 297(1-2):112-26. PubMed ID: 19038307
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Alterations in myocardial metabolism in the diabetic myocardium.
    Lazar HL
    Semin Thorac Cardiovasc Surg; 2006; 18(4):289-92. PubMed ID: 17395024
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Endothelial injury in the initiation and progression of vascular disorders.
    Tesfamariam B; DeFelice AF
    Vascul Pharmacol; 2007 Apr; 46(4):229-37. PubMed ID: 17218160
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Oxidative stress and endothelium dysfunction in diabetes mellitus type 2].
    Piwowar A; Knapik-Kordecka M; Warwas M
    Pol Merkur Lekarski; 2008 Aug; 25(146):120-3. PubMed ID: 18942329
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Can C-peptide mediated anti-inflammatory effects retard the development of microvascular complications of type 1 diabetes?
    Luppi P; Kallas Å; Wahren J
    Diabetes Metab Res Rev; 2013 Jul; 29(5):357-62. PubMed ID: 23463541
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Macroangiopathy in adults and children with diabetes: from molecular mechanisms to vascular damage (part 1).
    Di Marzio D; Mohn A; Mokini ZH; Giannini C; Chiarelli F
    Horm Metab Res; 2006 Nov; 38(11):691-705. PubMed ID: 17111296
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Control of atherosclerosis in diabetes mellitus].
    Quiroz Martínez A
    Arch Cardiol Mex; 2003; 73 Suppl 1():S125-7. PubMed ID: 12966662
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The early effects of elevated glucose on endothelial function as a target in the treatment of type 2 diabetes.
    Triggle CR
    Timely Top Med Cardiovasc Dis; 2008 Feb; 12():E3. PubMed ID: 18392213
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Macroangiopathy in adults and children with diabetes: risk factors (part 2).
    Di Marzio D; Mohn A; de Martino M; Chiarelli F
    Horm Metab Res; 2006 Nov; 38(11):706-20. PubMed ID: 17111297
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Role of postprandial hyperglycemia in cardiovascular disease.
    Fava S
    Expert Rev Cardiovasc Ther; 2008 Jul; 6(6):859-72. PubMed ID: 18570623
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Endothelial dysfunction in type 1 diabetes].
    Bertoluci MC; Cé GV; da Silva AM; Puñales MK
    Arq Bras Endocrinol Metabol; 2008 Mar; 52(2):416-26. PubMed ID: 18438553
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Another piece of cell biology in the puzzle of inflammation, glucose and diabetic vascular disease.
    Dilley RJ; Little PJ
    J Hypertens; 2008 Mar; 26(3):396-8. PubMed ID: 18300846
    [No Abstract]   [Full Text] [Related]  

  • 56. Trans fatty acids - effects on systemic inflammation and endothelial function.
    Mozaffarian D
    Atheroscler Suppl; 2006 May; 7(2):29-32. PubMed ID: 16713393
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Oxidative stress in diabetes: a mechanistic overview of its effects on atherogenesis and myocardial dysfunction.
    Mehta JL; Rasouli N; Sinha AK; Molavi B
    Int J Biochem Cell Biol; 2006; 38(5-6):794-803. PubMed ID: 16442834
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Oxidative stress and endothelial dysfunction.
    Muller G; Goettsch C; Morawietz H
    Hamostaseologie; 2007 Feb; 27(1):5-12. PubMed ID: 17279271
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Postprandial hyperglycemia/hyperlipidemia (postprandial dysmetabolism) is a cardiovascular risk factor.
    O'Keefe JH; Bell DS
    Am J Cardiol; 2007 Sep; 100(5):899-904. PubMed ID: 17719342
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Manipulating the vascular biology of coronary atherosclerosis in diabetes: new opportunities.
    Orford JL; Kinlay S; Fernandes J; Behrendt D; Ganz P; Selwyn AP
    J Lab Clin Med; 2001 Feb; 137(2):82-92. PubMed ID: 11174464
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.